Detection of HER2 overexpression in biliary tract cancers: Comparison of AmoyDx® HER-2 (29D8) assay with ventana PATHWAY anti-HER-2/neu (4B5) assay-MedSci.cn

Detection of HER2 overexpression in biliary tract cancers: Comparison of AmoyDx® HER-2 (29D8) assay with ventana PATHWAY anti-HER-2/neu (4B5) assay

Dong, H; Su, W; Lu, H; Liu, Z; Tang, Z; Huang, Z; Ruan, L; Zhu, C

ANNALS OF ONCOLOGY, 2023; 34 (): S223

科室
- - 订阅+
  - 更多科室
工具
服务